Genmab
GMAB
#1131
Rank
NZ$34.16 B
Marketcap
NZ$55.11
Share price
-0.87%
Change (1 day)
48.35%
Change (1 year)

Genmab (GMAB) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$2.20 Billion

According to Genmab's latest financial reports the company's total liabilities are NZ$2.20 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Genmab - Total liabilities on balance sheet (from 2018 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$0.31 B145.93%
2023-12-31NZ$0.12 B38.12%
2022-12-31NZ$92.61 M12.27%
2021-12-31NZ$82.49 M7.74%
2020-12-31NZ$76.56 M109.3%
2019-12-31NZ$36.58 M133.88%
2018-12-31NZ$15.64 M29.27%
2017-12-31NZ$12.09 M1.65%
2016-12-31NZ$11.9 M-8.73%
2015-12-31NZ$13.04 M-54.04%
2014-12-31NZ$28.37 M-36.52%
2013-12-31NZ$44.7 M-10.66%
2012-12-31NZ$50.03 M19.14%
2011-12-31NZ$41.99 M-27.39%
2010-12-31NZ$57.83 M22.52%
2009-12-31NZ$47.2 M-27.1%
2008-12-31NZ$64.75 M20.51%
2007-12-31NZ$53.73 M512.19%
2006-12-31NZ$8.77 M-5.09%
2005-12-31NZ$9.24 M118.79%
2004-12-31NZ$4.22 M2.54%
2003-12-31NZ$4.12 M-46.47%
2002-12-31NZ$7.7 M